EU approves Sivantos and Widex $8.3 billion hearing aid merger
February 20, 2019
Sivantos, headquartered in Singapore, is operating hearing devices by using data obtained from an electromyography of a user’s auricular muscle.
Sivantos and Widex have won EU approval for their $8.3 billion hearing aid merger.
Related Posts
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…